Evidence map›Paper›PMID 29343718›Full record

ArticleScientific reports2018

The bacterial Type III toxin-antitoxin system, ToxIN, is a dynamic protein-RNA complex with stability-dependent antiviral abortive infection activity.

Francesca L Short, Chidiebere Akusobi, William R Broadhurst, George P C Salmond

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
3.9field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 48 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Review
  6. Article
  7. Construction of antibiotic-free riboflavin producer inSynthetic and systems biotechnology · 2025
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Review
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 2 countries.

Francesca L ShortDepartment of Biochemistry, Hopkins Building, Downing Site, Tennis Court Road, University of Cambridge, Cambridge, CB2 1QW, UK.
Chidiebere AkusobiDepartment of Biochemistry, Hopkins Building, Downing Site, Tennis Court Road, University of Cambridge, Cambridge, CB2 1QW, UK.
William R BroadhurstDepartment of Biochemistry, Hopkins Building, Downing Site, Tennis Court Road, University of Cambridge, Cambridge, CB2 1QW, UK.
George P C SalmondDepartment of Biochemistry, Hopkins Building, Downing Site, Tennis Court Road, University of Cambridge, Cambridge, CB2 1QW, UK. gpcs2@cam.ac.uk.
University of Cambridge · GBHarvard University · USWellcome Sanger Institute · GB

Funding

Medical Scientist Training ProgramT32GM007753 · NIGMS · HARVARD UNIVERSITY (MEDICAL SCHOOL) · PI WALENSKY, LOREN DAVID · 1985 to 2021
$50.0M
Biotechnology and Biological Sciences Research Council BB/H002677/1NIGMS NIH HHS T32 GM007753
6 · The paper itself

Abstract

Bacteria have evolved numerous defense systems to protect themselves from viral (bacteriophage) infection. The ToxIN system of Pectobacterium atrosepticum is a Type III toxin-antitoxin complex and "altruistic suicide" anti-phage system, which kills phage-infected cells through the release of a ribonuclease toxin, ToxN. ToxN is counteracted by a co-transcribed antitoxic RNA pseudoknot, ToxI, which self-assembles with ToxN into an inactive 3 ToxI:3 ToxN complex in vitro. However it is not known whether this complex is predominant in vivo, or how the complex is disassembled following infection to trigger a lethal, "altruistic" response. In this study, we characterise ToxI turnover and folding, and explore the link between complex stability and anti-phage activity, with a view to understanding events that lead to ToxN-mediated suicide following phage infection. We present evidence that ToxN constantly cleaves fresh ToxI in vivo rather than staying associated with pre-processed antitoxin, and that the ToxI antitoxin can partially fold spontaneously using conserved nucleotides. We also show that reducing the stability of the ToxIN complex can increase the strength of the antiviral response in a phage-dependent manner. Based on this information, we propose a revised model for ToxN inhibition, complex assembly and activation by infecting bacteriophage.

Indexed as

Gene Expression Regulation, BacterialAntitoxinsBacterial ProteinsBacteriophagesBase PairingNucleic Acid ConformationPectobacteriumProtein BindingProtein FoldingProtein StabilityRibonucleasesRNA, BacterialToxin-Antitoxin SystemsTranscription, GeneticAntitoxinsBacterial ProteinsRibonucleasesRNA, Bacterial

Identifiers

PMID29343718
PMCPMC5772629
OpenAlexW2783474878

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.